Versartis, Inc. announced the promotion of Joshua T. Brumm to Chief Operating Officer and Paul Westberg to Chief Business Officer. Mr. Brumm had been serving as Chief Financial Officer and will continue in that role and Mr. Westberg was previously Senior Vice President, Corporate Development. Mr. Brumm has more than a decade of operations, corporate finance and investment banking experience in the life science industry. Prior to Versartis, he served as Executive Vice President of Finance and Principal Financial Officer for Pharmacyclics Inc. Mr. Westberg has more than twenty years of transactions, operations, and advisory experience focused on advancing innovative technologies/products in the life sciences sector.  He joinedVersartis from Bayhill Therapeutics.